Cointime

Ashvattha Therapeutics

company

About

Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.

  • 11 - 50

Highlights

Total Funding Amount
$29M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Convertable Note
Last Funding Money Raised
$22M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$29M
Ashvattha Therapeutics has raised a total of $29M in funding over 2 rounds. Their latest funding was raised on May 31, 2020 from a Convertable Note round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 31, 2020 Convertable Note $22M 2 Natural Capital — Detail
Mar 15, 2019 Series A $7M 1 Natural Capital — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Ashvattha Therapeutics is funded by 2 investors. Natural Capital and Zephyr Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Natural Capital Yes Convertable Note
Zephyr Venture Partners — Convertable Note
Cointime
Chủ Đề
Công Ty